Heather Preston, M.D.

Back to Jobs

Heather Preston, M.D. has served on our board of directors since August 2010. Dr. Preston has served as a managing partner at Pivotal bioVenture Partners, a life sciences venture capital fund, since July 2018. Dr. Preston has also served as a Senior Advisor at TPG Biotech, since July 2018, where she was previously a Partner and Managing Director from May 2005 to July 2018. She has served on the boards of directors of Alder Biopharmaceuticals since August 2010, of Oxford BioMedica since March 2018, of Entasis Therapeutics Holdings since August 2017, and of Karuna Therapeutics since 2019. Dr. Preston served on the board of directors of Albireo Pharma from 2008 to June 2018. Prior to joining TPG, Dr. Preston served for two years as a medical device and biotechnology venture capital investor at JP Morgan Partners, LLC. Prior to that, she was an Entrepreneur-in-Residence at New Enterprise Associates, a venture capital firm. From 1997 to 2002, Dr. Preston served as a leader of the pharmaceutical and medical products consulting practice of McKinsey & Co in New York. Dr. Preston holds a B.Sc.Hons degree in biochemistry from the University of London and an M.B.B.Chir degree in medicine from the University of Oxford. After leaving Oxford, Dr. Preston completed a post-doctoral fellowship in molecular biology at the Dana Farber Cancer Institute, Harvard University. Dr. Preston completed her training in Internal Medicine at the Massachusetts General Hospital and then sub-specialized in Gastroenterology and Hepatology at U.C.S.F. During Dr. Preston’s academic career, she was the recipient of a Fulbright Scholarship, a Fulbright Cancer Research Scholarship, a Harlech Scholarship and a Science and Engineering Research Council Post-doctoral Fellowship Award.

Apply Now